Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2008
09/17/2008CN100419075C Hybridoma cell strain capable of excreting monoclonal antibody of human carboxylesterase 2 and monoclonal antibody of human carboxylesterase 2
09/17/2008CN100418984C N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
09/16/2008US7425622 Antibodies against C3a receptor
09/16/2008US7425621 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders
09/16/2008US7425620 FcγRIIB-specific antibodies and methods of use thereof
09/16/2008US7425619 FcγRIIB specific antibodies and methods of use thereof
09/16/2008US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
09/16/2008US7425617 Antibodies to the cell cycle regulatory protein p16
09/16/2008US7425613 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic
09/16/2008US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders
09/16/2008US7425609 PRO4330 polypeptides
09/16/2008US7425605 PRO1486 polypeptides
09/16/2008US7425540 Method for modification of NMDA receptors through inhibition of Src
09/16/2008US7425450 Regulatable growth of filamentous fungi
09/16/2008US7425435 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis
09/16/2008US7425434 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy
09/16/2008US7425433 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
09/16/2008US7425429 Method for the identification of tissue-specific regulatory sequences
09/16/2008US7425423 Catalyzes template directed polymerization of DNA, possesses 3'-5'-exonuclease (proofreading) activity and is characterized by at least two-fold greater replication fidelity the DNA polymerase obtainable from Pyrococcus furiosus; dodecylpolyethylene glycol and/or ethylphenolpolyethylene glycol stabilizer
09/16/2008US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal
09/16/2008US7425329 Methods for treating bone cancer pain by administering a nerve growth factor antagonist
09/16/2008US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies
09/16/2008CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs
09/16/2008CA2409748C Soluble ctla4 mutant molecules and uses thereof
09/16/2008CA2387738C Process for producing a product containing antihypertensive tripeptides
09/16/2008CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
09/16/2008CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods
09/16/2008CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist
09/16/2008CA2132091C Antibodies to alphavbeta3 integrin
09/16/2008CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
09/12/2008WO2008109410A1 Use of copper and glutamate in cell culture for production of polypeptides
09/12/2008WO2008109398A1 T4 bacteriophage bound to a substrate
09/12/2008WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin
09/12/2008WO2008108345A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008WO2008108325A1 Novel beta-galactoside-alpha-2,6-sialyltransferase, gene encoding the same and method for enhancing enzymatic activity
09/12/2008WO2008079359A3 Human antibodies that bind human il-12 and methods for producing
09/12/2008WO2008033520A3 Bifidobacterial gene sequences and their use
09/12/2008WO2006076041A3 Pan-her antagonists and methods of use
09/12/2008CA2679941A1 Use of copper and glutamate in cell culture for production of polypeptides
09/12/2008CA2679926A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008CA2679703A1 A novel .beta.-galactoside-.alpha.2,6-sialyltransferase, a gene encoding thereof, and a method for enhancing enzyme activity
09/11/2008US20080222756 Nucleic acid constructs and methods for producing altered seed oil compositions
09/11/2008US20080222740 Improved properties such as temperature and/or pH stability, pH activity profile, temperature activity profile, substrate profile, improved performance in animal feed in vitro or in vivo
09/11/2008US20080222739 Cwp84, FliC and FliD proteins known to have conserved peptide sequences separately injected into female chickens, and the antibody rich egg yolks harvested
09/11/2008US20080221311 Preparation method of insect cell extract solution for cell-free protein synthesis, the insect cell extract solution and cell-free synthesis method of protein using the insect cell extract solution
09/11/2008US20080221309 MN Gene and Protein
09/11/2008US20080221305 Polynucleotides encoding novel adiponectin receptor variants
09/11/2008US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types
09/11/2008US20080220480 Removing H2O from atmospheric air, obtaining H2 from the H2O, obtaining CO2 from the air, and converting the CO2 to methanol; the methanol can be dehydrated to produce dimethyl ether or further processed to produce synthetic hydrocarbons, polymers, and other products; fossil fuel alternative
09/11/2008US20080220479 Expression vector comprising nucleotide sequences coding cytokine receptor specific immunoglobulin for treatment and prevention of inflammation, cartilage degradation and bone resorption
09/11/2008US20080220478 Using transgenic cell as bioreactor for propagating multimeric proteins
09/11/2008US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis
09/11/2008US20080220476 Thermostable Alpha-Amylases
09/11/2008US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS
09/11/2008US20080220474 Using transgenic yeast comprising omega -3 and/or omega -6 fatty acid promoters as bioreactor for heterologous gene expression
09/11/2008US20080220473 Endo-N-Acetyl-Beta-D-Glucosaminidase Enzymes of Filamentous Fungi
09/11/2008US20080220472 In Vivo Incorporation of Alkynyl Amino Acids into Proteins in Eubacteria
09/11/2008US20080220471 Nucleotide sequences coding Tet repressor (TetR) protein for use as gene targeting tool in genetic engineering
09/11/2008US20080220470 Protein hydrolysate rich in tripeptides
09/11/2008US20080220460 Modified flavin adenine dinucleotide dependent glucose dehydrogenase
09/11/2008US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR
09/11/2008US20080220431 Cell fusion method
09/11/2008US20080220417 Novel Alanine Transaminase Enzymes and Methods of Use
09/11/2008US20080220410 Method for replicating the hepatitis c virus
09/11/2008US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering
09/11/2008US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents
09/11/2008US20080220007 Ehrlichia canis genes and vaccines
09/11/2008US20080220002 Modified transferin-antibody fusion proteins
09/11/2008US20080219999 Immunoadhesin for the prevention of rhinovirus infection
09/11/2008US20080219997 Her-2 binding antagonists
09/11/2008US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells
09/11/2008US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy
09/11/2008US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
09/11/2008US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
09/11/2008US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders
09/11/2008US20080219952 culturing a human interferon producing cells in a serum-free medium, comprising hydroxyethyl piperazinyl ethanesulfonic acid(HEPES), proline sodium chloride and phenol red; drugs used for treating multiple sclerosis, viral diseases or cancer
09/11/2008US20080219925 Delta opioid receptor protein
09/11/2008US20080219924 Imaging, diagnosis and treatment of disease
09/10/2008EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer
09/10/2008EP1967585A1 Method for gene amplification
09/10/2008EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies
09/10/2008EP1967524A1 Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
09/10/2008EP1966388A2 Targeting vector-phospholipid conjugates
09/10/2008EP1819816B1 Methods for the production and secretion of modified peptides
09/10/2008EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments
09/10/2008EP1451222B1 Proteins with il-6 inhibiting activity
09/10/2008EP1412504B1 Methods of rna and protein synthesis
09/10/2008EP1401851B8 Two-stage protective groups for the synthesis of biopolymers
09/10/2008EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
09/10/2008EP1200124B1 Erythropoietin-immunoglobulin fusion proteins
09/10/2008EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma
09/10/2008EP1127154B1 Method for the production of fvii
09/10/2008EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies
09/10/2008EP0832245B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme
09/10/2008CN101260421A Method for preparing whey protein peptide by composite protease hydrolysis
09/10/2008CN101260420A Method for preparing protein filling material for leather preparation by using leather preparation barilla leather leftover material as raw material
09/10/2008CN101260401A Gene encoding a marker for cancer
09/10/2008CN101260397A Immobilization proteinase and application method thereof in preparing cream protein peptide
09/10/2008CN101260156A Immunoglobulin single variant antigen binding domain and specific construct thereof
09/10/2008CN101260149A Streptococcus antigens